“Dietary Nutrient Intake and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2”, Ophthalmology, vol. 128, no. 3, pp. 425-442, 2021.
, “Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.”, Ophthalmology, vol. 128, no. 1, pp. 100-109, 2021.
, “Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.”, Alzheimers Dement, vol. 16, no. 6, pp. 831-842, 2020.
, “Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.”, Ophthalmology, 2020.
, “Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 22.”, JAMA Ophthalmol, 2020.
, “Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.”, Ophthalmology, 2020.
, “Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.”, Ophthalmol Retina, vol. 4, no. 1, pp. 3-12, 2020.
, “The Association of Aspirin Use with Age-Related Macular Degeneration Progression in the Age-Related Eye Disease Studies: Age-Related Eye Disease Study 2 Report No. 20.”, Ophthalmology, vol. 126, no. 12, pp. 1647-1656, 2019.
, “Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39.”, JAMA Ophthalmol, vol. 137, no. 5, pp. 543-550, 2019.
, “Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.”, Ophthalmology, vol. 126, no. 4, pp. 540-549, 2019.
, “Imaging Characteristics of Choroidal Neovascular Lesions in the AREDS2-HOME Study: Report Number 4.”, Ophthalmol Retina, vol. 3, no. 4, pp. 326-335, 2019.
, “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.”, Ophthalmology, vol. 126, no. 2, pp. 261-273, 2019.
, “No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No.”, Ophthalmology, vol. 126, no. 11, pp. 1541-1548, 2019.
, “Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
, “ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S79-S88, 2018.
, “Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.”, Ophthalmology, vol. 125, no. 4, pp. 512-521, 2018.
, “CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S43-S50, 2018.
, “CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.”, Retina, vol. 38 Suppl 1, pp. S8-S13, 2018.
, “CORRELATION OF STRUCTURAL AND FUNCTIONAL OUTCOME MEASURES IN A PHASE ONE TRIAL OF CILIARY NEUROTROPHIC FACTOR IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.”, Retina, vol. 38 Suppl 1, pp. S27-S32, 2018.
, “A Deep Phenotype Association Study Reveals Specific Phenotype Associations with Genetic Variants in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 (AREDS2) Report No. 14.”, Ophthalmology, vol. 125, no. 4, pp. 559-568, 2018.
, “Genome-wide analysis of disease progression in age-related macular degeneration.”, Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.
, “LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.”, Retina, vol. 38 Suppl 1, pp. S20-S26, 2018.
, “Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”, Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
, “Treatment of Geographic Atrophy with Intravitreal Sirolimus: The Age-Related Eye Disease Study 2 Ancillary Study.”, Ophthalmol Retina, vol. 2, no. 5, pp. 441-450, 2018.
, “Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores.”, Genetics, vol. 206, no. 1, pp. 119-133, 2017.
,